EUVIMEDEUVIMED entdecken
Crossref

Anlotinib plus radiotherapy or chemoradiotherapy in locally advanced or advanced esophageal squamous cell carcinoma: A multicohort, real-world study

Guo-Jie Feng, Cheng-Rui Fu, Fan Wang, Jian-Cheng Li, Yue Jiang, Xin-Yi Wang, Bai-Hua Yang, Wen-Cai Xu, Yao-Wen Zhang, Xin-Yu Cheng, Xiao-Lin Ge, Xiao-Jie Xia und 6 weitere

World Journal of Gastroenterology · 28.07.2026

DOI: 10.3748/wjg.123331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 28.07.2026. Verfasst von Guo-Jie Feng und 17 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Feng, G., Fu, C., Wang, F., Li, J., Jiang, Y., Wang, X., Yang, B., Xu, W., Zhang, Y., Cheng, X., Ge, X., Xia, X., Xi, H., Zhao, X., Ma, H., Zhao, X., Wang, X., & Li, B. (2026). Anlotinib plus radiotherapy or chemoradiotherapy in locally advanced or advanced esophageal squamous cell carcinoma: A multicohort, real-world study. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.123331

Vancouver

Feng G, Fu C, Wang F, Li J, Jiang Y, Wang X, et al. Anlotinib plus radiotherapy or chemoradiotherapy in locally advanced or advanced esophageal squamous cell carcinoma: A multicohort, real-world study. World Journal of Gastroenterology. 2026. doi:10.3748/wjg.123331

BibTeX
@article{Feng2026,
  author = {Feng, Guo-Jie and Fu, Cheng-Rui and Wang, Fan and Li, Jian-Cheng and Jiang, Yue and Wang, Xin-Yi and Yang, Bai-Hua and Xu, Wen-Cai and Zhang, Yao-Wen and Cheng, Xin-Yu and Ge, Xiao-Lin and Xia, Xiao-Jie and Xi, He-Ming and Zhao, Xue-Song and Ma, Hong-Bing and Zhao, Xi-Xi and Wang, Xin and Li, Bao-Sheng},
  title = {Anlotinib plus radiotherapy or chemoradiotherapy in locally advanced or advanced esophageal squamous cell carcinoma: A multicohort, real-world study},
  journal = {World Journal of Gastroenterology},
  year = {2026},
  doi = {10.3748/wjg.123331}
}
Kostenlos starten →